Co-Diagnostics Inc
NASDAQ:CODX
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Teladoc Health Inc
NYSE:TDOC
|
Health Care
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Hims & Hers Health Inc
NYSE:HIMS
|
Health Care
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
Lockheed Martin Corp
NYSE:LMT
|
Aerospace & Defense
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Eli Lilly and Co
NYSE:LLY
|
Pharmaceuticals
|
|
US |
Walmart Inc
NYSE:WMT
|
Retail
|
|
US |
Micron Technology Inc
NASDAQ:MU
|
Semiconductors
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
1.01
1.75
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Teladoc Health Inc
NYSE:TDOC
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Hims & Hers Health Inc
NYSE:HIMS
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
Lockheed Martin Corp
NYSE:LMT
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Eli Lilly and Co
NYSE:LLY
|
US | |
Walmart Inc
NYSE:WMT
|
US | |
Micron Technology Inc
NASDAQ:MU
|
US |
This alert will be permanently deleted.
Co-Diagnostics Inc
PP&E Net
Co-Diagnostics Inc
PP&E Net Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | PP&E Net | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
Co-Diagnostics Inc
NASDAQ:CODX
|
PP&E Net
$5.3m
|
CAGR 3-Years
52%
|
CAGR 5-Years
93%
|
CAGR 10-Years
N/A
|
||
Becton Dickinson and Co
NYSE:BDX
|
PP&E Net
$6.8B
|
CAGR 3-Years
2%
|
CAGR 5-Years
4%
|
CAGR 10-Years
7%
|
||
Boston Scientific Corp
NYSE:BSX
|
PP&E Net
$3.5B
|
CAGR 3-Years
11%
|
CAGR 5-Years
12%
|
CAGR 10-Years
9%
|
||
Stryker Corp
NYSE:SYK
|
PP&E Net
$3.9B
|
CAGR 3-Years
8%
|
CAGR 5-Years
7%
|
CAGR 10-Years
14%
|
||
Abbott Laboratories
NYSE:ABT
|
PP&E Net
$10.2B
|
CAGR 3-Years
5%
|
CAGR 5-Years
3%
|
CAGR 10-Years
6%
|
||
Intuitive Surgical Inc
NASDAQ:ISRG
|
PP&E Net
$4.4B
|
CAGR 3-Years
37%
|
CAGR 5-Years
30%
|
CAGR 10-Years
29%
|
Co-Diagnostics Inc
Glance View
Co-Diagnostics, Inc. engages in the development and innovation of molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications. The company is headquartered in Salt Lake City, Utah and currently employs 101 full-time employees. The company went IPO on 2017-07-12. The firm is engaged in developing, manufacturing and marketing diagnostics technology. Its reagents are used for diagnostic tests that function via the detection and/or analysis of nucleic acid molecules, such as deoxyribonucleic acid and ribonucleic acid. The company also sells diagnostic equipment from other manufacturers as self-contained lab systems (MDx device). The firm uses its proprietary test design system and proprietary reagents to design and sell polymerase chain reaction diagnostic tests for diseases and pathogens starting with tests for tuberculosis, a drug resistant tuberculosis test, hepatitis B and C, Malaria, dengue, human immunodeficiency virus and Zika virus, all of which tests have been designed and validated in its laboratory. Its diagnostics systems enable molecular testing for organisms and genetic diseases by automating historically complex procedures in both the development and administration of tests.
See Also
What is Co-Diagnostics Inc's PP&E Net?
PP&E Net
5.3m
USD
Based on the financial report for Sep 30, 2024, Co-Diagnostics Inc's PP&E Net amounts to 5.3m USD.
What is Co-Diagnostics Inc's PP&E Net growth rate?
PP&E Net CAGR 5Y
93%
Over the last year, the PP&E Net growth was -8%. The average annual PP&E Net growth rates for Co-Diagnostics Inc have been 52% over the past three years , 93% over the past five years .